By Arne Alsin “Over the past thirty years, it seems the rich have gotten richer and the poor have gotten poorer. All the data support this: Homelessness has spiked in urban areas, while CEO pay has skyrocketed over the past three…
Author: admin
Slovenes rank above the EU average in citations, but lower for patent applications
By Tina Drolc “Vesna Žabkar, PhD, Professor and Vice-Dean of Research, FELU. Vesna Žabkar, PhD, is a full professor and Vice-Dean of Research at the Faculty of Economics, University of Ljubljana (FELU). Among the priorities of FELU research she highlights…
The Functions of the Stock Market and the Fallacies of Shareholder Value
By Institute for New Economic Thinking (INET) “Academic research on sources of corporate finance shows that, compared with other sources of funds, stock markets in advanced countries have been insignificant suppliers of capital for corporations. The purpose of this essay is…
US Pharma’s Financialized Business Model
By Institute for New Economic Thinking (INET) “In 1985 US Representative Henry Waxman, chair of the House Subcommittee on Health and the Environment, accused the pharmaceutical industry of “gouging the American public” with “outrageous” price increases, driven by “greed on a…
After passing stress tests, Wall Street banks to spend like a drunken sailor – on their own stock buybacks
By Pam Martens and Russ Martens “Yesterday, the Federal Reserve announced the second leg of its 2017 stress tests for the nation’s most systemic financial institutions. Known as the Comprehensive Capital Analysis and Review (CCAR), the Fed said it “did not object…
Q&A: Economist William Lazonick on stock buyback mania that’s threatening the US economy
By Arne Alsin “A few years ago, the economist William Lazonick was contacted by an editor at Harvard Business Review and asked if he’d be interested in writing about his latest research on stock buybacks. Lazonick was surprised.”… [Click HERE…
The $31 billion hole in GE’s balance sheet that keeps growing
By Katherine Chiglinsky, Brandon Kochkodin, and Rick Clough “It’s a problem that Jeffrey Immelt largely ignored as he tried to appease General Electric Co.’s most vocal shareholders. But it might end up being one of the costliest for John Flannery,…
“Prezzi altissimi, speculazione, zero ricera: Fermiano le industrie farmaceutiche
By Fabrizio Patti “L’attività di comprare azioni proprie, da parte delle aziende, sarebbe considerata un’attività normale dal 99% degli economisti. Ma non certo da William Lazonick, che vieterebbe la pratica domani stesso, fosse per lui.”… [Click HERE to read the full…
It’s time for Trump to do something about high CEO pay
By Steven Clifford and Sarah Anderson “The House is expected to vote Thursday on a Wall Street deregulation plan that would roll back several Obama-era CEO pay reforms, including a ban on banker bonuses that encourage excessive risk, and a…
Avidità che uccide: il business Big Pharma
Anonymous “Roberto Mania, giornalista di Repubblica, ha introdotto la lezione del professor William Lazonick, economista dell’Università del Massachusetts a Lowell, illustrando come negli anni, durante la cavalcata dell’ideologia liberista, sia mancato un pensiero critico, una voce alternativa.”… [Click HERE to…
